Illumina, Inc. today introduced the world's largest genome-wide genetic perturbation dataset, being built to accelerate drug ...

See how to monitor your health, sleep, and physical exercise with the help of wearables, smart wearable electronics, with ...

Aging-focused biotech companies share how they're advancing therapies to slow disease, extend lifespan, and transform medicine.

Heart disease remains the leading cause of death worldwide, yet progress in understanding and treating cardiac disorders is ...

Pioneering research by experts at the University of Sydney, the Baird Institute and the Royal Prince Alfred Hospital in ...

The adult mammalian heart bears limited regenerative capacity, resulting in the irreversible loss of cardiomyocytes post-cardiac injury, and often culminating in end-stage heart failure. Cardiomyocyte ...

Though rare, sudden cardiac arrest (SCA) in athletes often unfolds in high-visibility settings, like sports arenas, prompting ...

Piezoelectric nanoparticles deployed inside immune cells and stimulated remotely by ultrasound can trigger the body's disease ...

Cell therapies, often described as ‘living therapies’, are transforming cancer treatment. These drugs harness the power of the immune system to deliver remarkable results, particularly for blood ...

Akebia Therapeutics is refocusing on Vafseo for dialysis patients, discontinuing expansion to non-dialysis, which has reset ...

Americore Resources Corp. (TSXV: AMCO) (OTCQB: AMCOF) is moving aggressively to unlock the next major silver district in Nevada, having just commenced its 2026 field program at the Trinity Silver ...

Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...